PubMed, Lu, Jingtong, et al
Systemic effects that have been reported in trials, or that are mechanistically expected from elevated GH and IGF-1, include: Water retention and mild edema , particularly in the hands, ankles, and face Tingling, numbness, or 'pins and needles' (paresthesia) , sometimes linked to fluid pressure on nerves Headache and facial flushing , often shortly after administration Joint aches or stiffness (arthralgia) Transient changes in blood glucose due to GH's counter-regulatory effect on insulin Fatigue, dizziness, or a feeling of light-headedness in some individuals It is important to be candid about the limits of this evidence
What Healthcare Providers May Do During evaluation, a clinician may: Ask about diet, hydration, medications, supplements, and recent illness Review timing of symptoms in relation to semaglutide dosing Check blood glucose levels Order urine tests for infection, ketones, or kidney function Request blood tests if needed These steps help determine whether treatment, medication adjustments, or further testing is needed
It is not known if this is a direct result of the illness or other comorbid factors
